FDA NDA · NDA021951

ABSORICA

isotretinoin

Sponsor: SUN PHARM INDS INC

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
NDA021951
TYPE
NDA
ORIGINAL APPROVAL
2012-05-25
LATEST ACTION
2026-10-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ABSORICA · ReferencePrescription
ISOTRETINOIN 35MG · CAPSULE · ORAL
ABSORICA · ReferencePrescription
ISOTRETINOIN 40MG · CAPSULE · ORAL
ABSORICA · ReferencePrescription
ISOTRETINOIN 20MG · CAPSULE · ORAL
ABSORICA · ReferencePrescription
ISOTRETINOIN 25MG · CAPSULE · ORAL
ABSORICA · ReferencePrescription
ISOTRETINOIN 30MG · CAPSULE · ORAL
ABSORICA · ReferencePrescription
ISOTRETINOIN 10MG · CAPSULE · ORAL

Approval history

2026-10-07REMS · Supplement 32 — Letter ↗AP
2026-08-11Labeling · Supplement 31 · standard — Letter ↗AP
2026-06-12Labeling · Supplement 29 · standard — Label ↗AP
2026-02-09REMS · Supplement 28 — Letter ↗AP
2024-06-28Labeling · Supplement 16 · standard — Label ↗AP
2023-07-18Labeling · Supplement 24 · standard — Label ↗AP
2023-07-18Labeling · Supplement 23 · standard — Letter ↗AP
2023-03-24REMS · Supplement 22 — Letter ↗AP
2022-10-06REMS · Supplement 21 — Letter ↗AP
2021-10-08REMS · Supplement 18 — Letter ↗AP
2020-12-09REMS · Supplement 17 — Letter ↗AP
2020-01-24REMS · Supplement 15 — Letter ↗AP
2019-11-07Labeling · Supplement 13 · standard — Letter ↗AP
2018-08-31Labeling · Supplement 14 · standard — Letter ↗AP
2018-05-02Labeling · Supplement 11 · standard — Letter ↗AP
2018-04-23REMS · Supplement 12 — Letter ↗AP
2017-06-17REMS · Supplement 10 — Letter ↗AP
2016-07-08REMS · Supplement 8 — Letter ↗AP
2016-02-04REMS · Supplement 7 — Letter ↗AP
2015-12-23Manufacturing (CMC) · Supplement 6 · standardAP
2015-09-03REMS · Supplement 5 — Label ↗AP
2014-10-20Manufacturing (CMC) · Supplement 4 · standardAP
2014-08-15Manufacturing (CMC) · Supplement 3 · standard — Letter ↗AP
2014-07-30Labeling · Supplement 1 · unknown — Label ↗AP
2012-05-25Type 3 - New Dosage Form · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →